Nutriband - NobleCon20 - Presentation Replay
Nutriband Inc. Announces Financial Results for the Third Quarter of 2024
Nutriband Inc. Issued Full Patent from the Chinese National Intellectual Property Administrant for Its "Abuse and Misuse Deterrent Transdermal System" Application
Nutriband Inc Mosquito Repellent Patch Approved by Ministry of Health of Costa Rica
Join Nutriband's Exclusive Live Investor Webinar and Q&A Session on October 17
Nutriband Receives China Patent Notice of Allowance for Its Aversa(TM) Abuse Deterrent Transdermal Technology
Nutriband Licenses Bitrex(R) Brand Aversive Agent for Its Lead Product - Aversa(TM) Fentanyl Transdermal Patch
Nutriband Inc. Authorizes $1M Share Buyback Program
Nutriband Inc. Quarterly Report Highlights Strong Cash Position, and Strategic Progress Toward NDA Filing for AVERSA Fentanyl in 2025
To find out more, or to enquire about our partnership options, please contact our team who can help find the right solution for your business.
